RB Goldberg, JR Guyton, T Mazzone, RS … - Mayo Clinic Proceedings, 2006 - mayoclinicproceedings.com RESULTS: A total of 1229 patients participated in the study. Significantly
greater mean reductions were found in LDL-C levels with ezetimibe/simvastatin,
10/20 mg/d (-53.6%; 95% confidence interval [CI], -55.4% to -51.8%), than ... Cited by 51 - Related articles - BL Direct - All 10 versions
- ►nih.gov [PDF] SJ Spann, PA Nutting, JM Galliher, KA … - The Annals of Family Medicine, 2006 - Annals Family Med RESULTS Participating clinicians (average age, 45.7 years) saw an average of
32.6 adult patients with diabetes per month. Patients (average age, 59.7 years)
reported a mean duration of diabetes of 9.1 years, with 34.3% having had ... Cited by 37 - Related articles - BL Direct - All 12 versions
AT Yan, RT Yan, M Tan, DG Hackam, KL Leblanc … - The American journal of medicine, 2006 - Elsevier Between December 2001 and December 2004, the prospective Vascular Protection and
Guidelines Oriented Approach to Lipid Lowering Registries recruited 8056
outpatients with diabetes, established cardiovascular disease (CVD), or ... Cited by 31 - Related articles - All 4 versions
J Kreyenbuhl, FB Dickerson, DR Medoff, CH … - The Journal of nervous and mental disease, 2006 - journals.lww.com *Division of Services Research, Department of Psychiatry, University of Maryland
School of Medicine, Baltimore, Maryland; †VA Capitol Health Care Network (VISN
5) Mental Illness Research, Education, and Clinical Center, Baltimore, ... Cited by 22 - Related articles - BL Direct - All 6 versions
RB Goldberg, VA Fonseca, KE Truitt, MR … - Archives of internal medicine, 2008 - archinte.highwire.org Methods A prospective, 16-week, multicenter, randomized, double-blind,
placebo-controlled, parallel-group study conducted at 50 sites in the United
States and 1 site in Mexico between August 12, 2004, and December 28, 2005. ... Cited by 18 - Related articles - All 5 versions
- ►nih.gov - Free from Publisher VA Fonseca, J Rosenstock, AC Wang, KE … - Diabetes care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A 26-week, randomized, double-blind,
placebo-controlled, parallel-group, multicenter study was carried out between
August 2004 and August 2006 to evaluate the efficacy and safety of ... Cited by 16 - Related articles - All 5 versions
OE Johansen - Scandinavian Journal of Clinical & Laboratory …, 2007 - informahealthcare.com Chronic hyperglycaemia (eg type 2 diabetes mellitus (T2DM) and prediabetes) in
humans is associated with an increased risk of cardiovascular (CV)
complications, and, vice versa, the presence of CV complications (eg ... Cited by 6 - Related articles - BL Direct - All 6 versions
M de Brito Gomes, D Gianella, M Faria, M … - The Review of Diabetic Studies, 2006 - pubmedcentral.nih.gov Major clinical studies have shown that the targets for blood glucose, lipid
profile and blood pressure in type 2 diabetic patients are difficult to maintain
in clinical practice. However, there are few data concerning South American ... Cited by 6 - Related articles - All 3 versions
G Bruno, F Merletti, G Bargero, D Melis, I … - Nutrition, Metabolism and Cardiovascular Diseases, 2008 - Elsevier Two population-based surveys, using similar methods and centralized
measurements, were conducted in 1988 and 2000 in a representative Italian area
to identify people with known diabetes. The adjusted prevalence (reference, ... Cited by 4 - Related articles - All 8 versions
- ►diabetesjournals.org [PDF] VA Fonseca, J Rosenstock, AC Wang, KE … - Diabetes Care, 2008 - Am Diabetes Assoc Page 1. Colesevelam Improves Glucose and Lipid Levels Colesevelam HCl Improves
Glycemic Control and Reduces LDL-Cholesterol in Patients ... Cited by 3 - Related articles - All 3 versions
